SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

   Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

       Date of Report (Date of Earliest Event Reported): April 11, 2002


                              INVACARE CORPORATION
                              --------------------
             (Exact Name of Registrant as Specified in its Charter)


                                      OHIO
                 (State or Other Jurisdiction of Incorporation)


            0-12938                                  95-2680965
      -------------------                       -------------------
     (Commission File No.)                (IRS Employer Identification No.)


               One Invacare Way, P.O. Box 4028, Elyria, Ohio 44036
              ----------------------------------------------------
                    (Address of Principal Executive Offices)


                                 (440) 329-6000
                                 --------------
              (Registrant's Telephone Number, Including Area Code)

--------------------------------------------------------------------------------
Item 5.  Other Events.

Invacare Corporation news release dated April 11, 2002.


News Release
                                                  Media Inquiries:
                                                  Susan A. Elder
                                                  Director of Marketing
                                                  Communications
                                                  (440) 329-6549

                                                  Investor Inquiries:
                                                  John Bingle
                                                  Director of Investor Relations
                                                  (440) 329-6379

Invacare Corporation Announces Resignation of its Chief Financial Officer

     ELYRIA, OH (April 11, 2002) - Invacare Corporation announced today that its
Chief Financial Officer, Thomas R. Miklich, is resigning to accept a position as
Chief Financial Officer of OM Group, Inc., a $6.0 billion international producer
and marketer of metal-based  specialty chemical products.  Miklich has served as
Invacare's chief financial officer and general counsel since joining the company
in 1993.

     Commenting on Miklich's  decision to resign,  Invacare  Chairman and CEO A.
Malachi  Mixon,  III,  said,  "Tom  has  been a  valuable  member  of my  senior
management team and has made many contributions to our success during his tenure
with  Invacare.  Although we will miss Tom, we understand his decision to pursue
an opportunity at a larger company, and we wish him well."

     Invacare  has  already  begun the  process  of  finding a  replacement  for
Miklich,  who will remain with  Invacare  for several  more weeks to assist in a
smooth and orderly transition.

     Commenting on his departure  from Invacare,  Miklich said,  "Invacare is an
outstanding  company,  and I have  thoroughly  enjoyed my long tenure  here.  My
decision to leave is based on the opportunity to move to a larger company,  with
which I also  have  had a long  relationship,  having  served  on the  board  of
directors of OM Group since 1993 when the company went public.  I wish  everyone
at Invacare continued success."

     Invacare  Corporation  (NYSE:  IVC) is the global leader in the manufacture
and  distribution of innovative home medical products which promote recovery and
active  lifestyles  through more than 25,000 providers.  The company,  which had
2001  revenues of $1.05  billion,  goes to market in the  following  channels of
distribution: home care, mass retail and institutional. Within these channels of
distribution,  Invacare  participates in the following  product  segments:  Home
Care, which includes rehab products,  respiratory products,  manual wheelchairs,
home care beds, therapeutic support surfaces and personal care products marketed
by Invacare's Home Care Group;  Soft Goods and Supplies,  which includes ostomy,
incontinence,  wound care and  diabetic  supplies  marketed by  Invacare  Supply
Group; and  Institutional,  which includes nursing home beds,  patient lifts and
slings,  nursing  home  furniture  and  bathing  systems  marketed  by  Invacare
Continuing Care Group. The company's  headquarters are in Elyria,  Ohio, and the
firm has manufacturing plants in the United States, Australia,  Canada, Denmark,
Germany,  France,  Mexico, New Zealand,  Portugal,  Sweden,  Switzerland and the
United Kingdom. For more information about the company, visit Invacare's website
at www.invacare.com.

                                                                      ###